Development of improved SRC-3 inhibitors as breast cancer therapeutic agents

Qin, L; Chen, JW; Lu, D; Jain, P; Yu, Y; Cardenas, D; Peng, XH; Yu, XB; Xu, JM; Wang, J; Malley, BWO; Lonard, DM

Lonard, DM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Lonard, DM (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.

ENDOCRINE-RELATED CANCER, 2021; 28 (10): 657